Stock's Trend Analysis Report -Halozyme Therapeutics, Inc. (NASDAQ:HALO), Amkor Technology, Inc. (NASDAQ:AMKR), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), Susquehanna Bancshares Inc (NASDAQ:SUSQ)

Lewes, DE -- (SBWire) -- 08/31/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Halozyme Therapeutics, Inc. (NASDAQ:HALO), Amkor Technology, Inc. (NASDAQ:AMKR), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), Susquehanna Bancshares Inc (NASDAQ:SUSQ).

Halozyme Therapeutics, Inc. (NASDAQ:HALO) increased 0.73% and closed at $8.31 on a traded volume of 1.39 million shares, in comparison to 1.44 million shares of average trading volume. So far this year, the stock is up over 24.96%.

The company has a total market capitalization of $941.40 million and its total outstanding shares are 113.29 million.

Will HALO Continue To Move Higher? Find Out Here

Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes.

Amkor Technology, Inc. (NASDAQ:AMKR) plunged -3.14% and closed at $4.01 on a traded volume of 1.41 million shares, whereas its average trading volume is 760.846 shares. In the last three months, the stock is down -13.02%. The Intra-day range for the stock is $4.00 and $4.15.

Will AMKR Get Buyers Even After The Recent Rally? Find Out Here

Amkor Technology, Inc. provides outsourced semiconductor packaging and test services in the United States and internationally.

Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) jumped 3.19% and closed at $1.94. So far in three months, the stock is up 110.87%. The 52-week range for the stock is $0.37 and $2.50 and during the previous trading session the stock touched its highest price at $1.98. Its introductory price for the day was $1.96, with the overall traded volume of 1.38 million shares.

Will CPRX Continue To Move Higher? Find Out Here

Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company.

Susquehanna Bancshares Inc (NASDAQ:SUSQ) after opening its shares at the price of $12.80, dropped -1.64% to close at $12.61 for the day. The stock moved on a traded volume of 1.37 million shares, in comparison to 874.983 shares of average trading volume.

The 52-week range for the stock is $9.19 and $14.35 and during the previous trading session the stock touched its highest price at $12.82.

Will SUSQ Get Buyers Even After The Recent Rally? Find Out Here

Susquehanna Bancshares, Inc. operates as the bank holding company for Susquehanna Bank that provides a range of retail and commercial banking, and financial products and services in the mid-Atlantic region.

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/

Media Relations Contact

News Department
http://leadingstockalerts.com/

View this press release online at: http://rwire.com/319157